Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene.

OBJECTIVE This study investigated the effect of the 102-T/C polymorphism in the 5-HT(2A) receptor gene on risperidone efficacy. METHOD One hundred Han Chinese patients with acutely exacerbated schizophrenia were given risperidone for up to 42 days. The patients were genotyped for 5-HT(2A) polymorphisms. Psychopathology was measured biweekly with the Positive and Negative Syndrome Scale while the patients were taking risperidone. Generalized estimating equation methods were used to analyze the effects of treatment duration, T/C genotypes, and other prognostic factors on Positive and Negative Syndrome Scale performance. RESULTS Patients with the C/C genotype had lower total scores, negative subscale scores, and general psychopathology scores but not positive subscale scores on the Positive and Negative Syndrome Scale than patients with the 102-T/C genotype. Patients with the T/C and T/T genotypes had comparable total and subscale scores. The number of previous hospitalizations and the dose of risperidone also affected Positive and Negative Syndrome Scale total scores. CONCLUSIONS These results suggest that variations in the 5-HT(2A) receptor gene may influence individual responses to risperidone.

[1]  Jeffrey A Lieberman,et al.  Serotonin Subtype 2 Receptor Genes and Clinical Response to Clozapine in Schizophrenia Patients , 1998, Neuropsychopharmacology.

[2]  M. J. Arranz,et al.  Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response , 1998, Schizophrenia Research.

[3]  A. Malhotra,et al.  Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. , 1996, The American journal of psychiatry.

[4]  S. Kapur,et al.  Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. , 2001, The American journal of psychiatry.

[5]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[6]  W. Chiu,et al.  Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels. , 2000, The Journal of clinical psychiatry.

[7]  H. Hwu,et al.  Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese , 1997, Psychiatric genetics.

[8]  J. Leysen,et al.  Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. , 1994, The Journal of clinical psychiatry.

[9]  M. Nöthen,et al.  Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene , 1996, The Lancet.

[10]  U. Ahlfors,et al.  The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.